Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate

2. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders In Q4 2024: 64

Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical firm that is one of the key players in the global weight loss drug market. As a result, weight loss drugs are tied into the firm’s hypothesis. The link was clear in December when Novo Nordisk A/S (NYSE:NVO)’s shares dipped by 17.8% after its weight loss drug trial missed market expectations. More recently, supply problems with Wegovy and potential Trump tariffs against pharmaceuticals have also driven the stock. Here is what Cramer said about Novo Nordisk A/S (NYSE:NVO):

“Now we don’t know what the President’s going to do. Is Novo Nordisk, cause they make some stuff but it’s a Danish company, where are they going to be in the tariffs?”

“Yeah because you already have Zepbound, why do you need Wegovy?”